SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending following a significant post-earnings sell-off, primarily driven by market concerns over decelerating Azure growth and substantial AI infrastructure capital expenditure. The community is intensely debating if this sharp dip represents an overreaction and a strategic buying opportunity, or if it signals a tougher path for AI monetization.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) is experiencing a sharp decline, heavily impacted by Bitcoin's significant drop and a broader crypto market selloff, sparking intense community debate. Many are vocal about the stock being a "Ponzi scheme" due to its leveraged Bitcoin strategy and continuous share dilution by Michael Saylor, predicting further capitulation and double-digit prices, while a contrarian group sees the deep dip as an oversold buying opportunity.

TechCreate Group Ltd. - Ordinary Shares - Class A

TCGL is trending after an astronomical, unexplained price surge and trading volume triggered multiple volatility halts, prompting community speculation about a potential short squeeze or a speculative pump and dump often seen with foreign micro-cap stocks.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is heavily trending as investors anticipate its crucial earnings report, with community sentiment sharply divided between expectations of a strong beat driven by iPhone sales and services growth, and concerns over potential margin pressures from rising memory costs and an unclear AI roadmap compared to peers. The market is also looking to Apple's results to potentially stabilize the broader tech sector after recent mixed mega-cap earnings.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is facing significant bearish sentiment and talk of market manipulation after a crypto market structure bill hit legislative roadblocks, leading many to question its store-of-value narrative against rising precious metals, even as some investors eye the current dip as a buying opportunity.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is generating significant buzz due to proposed credit card interest rate caps, which the community believes will boost its merchant-funded BNPL model, alongside recent stablecoin and AI initiatives positioning it as a future digital banking leader and an undervalued opportunity.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending after reporting an earnings beat and announcing a significant share repurchase program, yet its stock experienced a notable decline amid broader market fears about AI disruption impacting software valuations. The community is actively debating if the sell-off is overdone, with many seeing the dip as a manipulated opportunity to buy into a company they believe is an AI beneficiary.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as community discussion intensifies around the perceived competitive threat and market manipulation from prediction markets, even as the company approaches its crucial Q4 earnings report and the historically strong Super Bowl betting period. Despite analysts remaining largely bullish and reports of record online betting revenue in key states, investors are frustrated by the stock's continued underperformance.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending following strong earnings and optimistic guidance, with investors and analysts reacting positively to its AI investments showing tangible benefits in advertising revenue and user engagement. The community is highlighting numerous upgraded price targets, while contrasting its success with peers who also announce significant capital expenditures.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as an announced $1.2 billion capital raise, priced at a discount via common stock and convertible notes, fuels community discussion between immediate dilution concerns and long-term investor confidence in accelerating FAA certification and production scaling for its electric air taxis.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ALT where was it discovered that the lean mass preserving weight loss in pemvi’s trials wasn’t caused by it?  Even the placebo arm didn’t show it, although it outperformed all historical norms.

@BioRich here are three biotech gems.  Check them out - it’s more fun to be positive on stocks than a Negative Nancy.

LMK what you think about $TLSA $KYMR and $IXHL are all very intriguing to me (KYMR to hold for a buyout, TLSA &amp; IXHL to hold long like CCCC or IMRX).

Thoughts on these other ones?  We can formally agree to disagree on AltImmune.  I am a bull 🐂 and you are a 🐻 we all get it 🚀

Jan-Ulrich Janeczek

Huguenots

big candle

Flyonwall

@JuggernautRaider I appreciate the optimism.  It&#39;s fair to clarify that it&#39;s been discovered that $ALT&#39;s Lean Mass Preservation was not as a result of Pemvidutide so that argument is sort of off the plate at this point.   
 
Cheers to having the workplace foresight by the way.  Hopefully it&#39;s worked out to your liking. 
 
Cheers!

StockTwits Web

Altimmune Inc

The Legendary Mayor

I&#39;m genuinely curious about the reason behind those $KYMR buyout speculations. 

They have enough cash in the bank to get at least two wholly owned assets through phase 3 trials without limiting their research operations. They could become the next$REGN 

Why would they sell out now, or anytime soon?

StockTwits For Android 

Herman Cheruskian

StockTwits for iOS

Tiziana Life Sciences Ltd

Kymera Therapeutics Inc

Incannex Healthcare Limited - ADR

 where was it discovered that the lean mass preserving weight loss in pemvi’s trials wasn’t caused by it?  Even the placebo arm didn’t show it, although it outperformed all historical norms.



 here are three biotech gems.  Check them out - it’s more fun to be positive on stocks than a Negative Nancy.

LMK what you think about 

 are all very intriguing to me (KYMR to hold for a buyout, TLSA & IXHL to hold long like CCCC or IMRX).

Thoughts on these other ones?  We can formally agree to disagree on AltImmune.  I am a bull 🐂 and you are a 🐻 we all get it 🚀

Fortress Biotech Inc

SELLAS Life Sciences Group Inc

Tonix Pharmaceuticals Holding Corp

C4 Therapeutics Inc

Nuvation Bio Inc - Ordinary Shares - Class A

Immuneering Corp

Jeffs Brands

Jeff Conroy

@JuggernautRaider It has been published in publications that Lean Mass results were not dose dependent.  That&#39;s why they lump the results of the 50 they measured on Pemvi together, rather than per dosage (like they do every other measurement).   
 
Furthermore, $ALT has NEVER produced Placebo results for Lean Mass Perservation, which is further grows concern that control/comparison data has never been shared (which would further support the non-effect of Pemvi on LMP).   
 
Additional note, the weight loss for the subjects selected for the Placebo LMP subset was over 8%, vs. the 2.2% reported for the &quot;full&quot; set.   
 
As for the others...$TLSA is a monster.  Them and $CADL should get a deal soon.  Not was well versed with , $IMRX or $IVXL.  I am happy with $CCCC as well, just waiting for a big move with them too. 
 
So yes, we can agree to disagree with $ALT, but there are some excellent ones out there.

Michael Thomas Reinhardt

Matt Dunbar

Well we agree on $TLSA $SLS $CCCC and other biotech stocks so I’m glad you’re not one of of the many StockTwits Trolls or shorts.  I’m holding ALT long until convinced otherwise and while we agree on other criminally undervalued biopharma picks… let’s find some peace here, eh? ☮️ 

and if you think CADL is hot (and wasn’t their pancreatic cancer trial delayed??)… wait until you read up on $IMRX . They have a MEK inhibitor that looks like it can pair up with either FOLFIRINOX or Abraxane + gem in frontline PDAC to greatly improve overall survival in one of the deadliest cancers.  Much like NUVB and SLS i wish I had bought every share I could when it was &lt; $2.  C’est la vie 🤷‍♂️ 

Please feel free to share where you saw that ALT is intentionally withholding data because it doesn’t make sense.  Garg had many faults but pemvi was not one of them 💪

Candel Therapeutics Inc

 It has been published in publications that Lean Mass results were not dose dependent.  That's why they lump the results of the 50 they measured on Pemvi together, rather than per dosage (like they do every other measurement).   
 
Furthermore, 

 has NEVER produced Placebo results for Lean Mass Perservation, which is further grows concern that control/comparison data has never been shared (which would further support the non-effect of Pemvi on LMP).   
 
Additional note, the weight loss for the subjects selected for the Placebo LMP subset was over 8%, vs. the 2.2% reported for the "full" set.   
 
As for the others...

 should get a deal soon.  Not was well versed with , 

 as well, just waiting for a big move with them too. 
 
So yes, we can agree to disagree with 

, but there are some excellent ones out there.

Sanofi-Aventis

SPDR S&P Biotech ETF

Viking Therapeutics Inc

Milestone Pharmaceuticals Inc

Inventiva - ADR

Terns Pharmaceuticals Inc

Fractyl Health Inc.

@JuggernautRaider @BioRich @BioRich 

Biorich cannot be talked to rationally he&#39;s just one of those really annoying people. 

I&#39;m not sure how he even has an audience left, block him.

 

Biorich cannot be talked to rationally he's just one of those really annoying people. 

I'm not sure how he even has an audience left, block him.